XML 78 R65.htm IDEA: XBRL DOCUMENT v3.19.2
Commitments and Contingencies - Additional Information (Detail)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended 48 Months Ended
Jul. 31, 2019
USD ($)
Nov. 30, 2017
USD ($)
ft²
Sep. 30, 2019
USD ($)
Jun. 30, 2019
USD ($)
€ / $
Jun. 30, 2018
USD ($)
Jun. 30, 2019
USD ($)
€ / $
Jun. 30, 2019
EUR (€)
Jun. 30, 2018
USD ($)
Sep. 30, 2018
USD ($)
Dec. 31, 2023
USD ($)
Commitments And Contingencies [Line Items]                    
Settlement of claim           $ 400,000        
License agreement commencement date           2006-03 2006-03      
Annual minimum payments for licenses           $ 227,000 € 200,000      
Exchange rate relating to license payment | € / $       1.137   1.137        
Future minimum payments associated with license       $ 1,900,000   $ 1,900,000        
Rent expense related to operating leases       100,000 $ 100,000 400,000   $ 200,000    
Other long-term liabilities       4,755,000   $ 4,755,000     $ 5,720,000  
Acquisition charge for in-process of research and development         $ 7,888,000     $ 7,888,000    
Eden Prairie Minnesota [Member]                    
Commitments And Contingencies [Line Items]                    
Square feet facility | ft²   36,000                
Operating lease agreement term   10 years                
Operating lease agreement commencement date   2018-05                
Amount deposited into restricted cash account   $ 400,000                
Patents [Member]                    
Commitments And Contingencies [Line Items]                    
Patent expiry date           2027-09 2027-09      
Intellectual Property [Member] | Medical Device [Member]                    
Commitments And Contingencies [Line Items]                    
Contingency period ending year           2022 2022      
Intellectual Property [Member] | Medical Device [Member] | Subsequent Event [Member]                    
Commitments And Contingencies [Line Items]                    
Payments to acquire intellectual property assets $ 800,000                  
Contingent payments upon achievement of regulatory milestones 1,300,000                  
Estimated additional payment to acquire intellectual property assets $ 200,000                  
Intellectual Property [Member] | Scenario Forecast [Member] | Medical Device [Member]                    
Commitments And Contingencies [Line Items]                    
Acquisition charge for in-process of research and development     $ 900,000              
Intellectual Property [Member] | Embolitech LLC [Member]                    
Commitments And Contingencies [Line Items]                    
Payments to acquire intellectual property assets           $ 5,000,000        
Installment payment beginning period           2020-01 2020-01      
Installment payment ending period           2023-12 2023-12      
Contingent payments upon achievement of regulatory milestones           $ 2,000,000        
Contingency period ending year           2033 2033      
Other long-term liabilities       2,100,000   $ 2,100,000     2,900,000  
Other current liabilities       $ 1,000,000   1,000,000        
Intellectual Property [Member] | Embolitech LLC [Member] | Scenario Forecast [Member]                    
Commitments And Contingencies [Line Items]                    
Estimated additional payment to acquire intellectual property assets                   $ 3,500,000
Selling, general and administrative [Member]                    
Commitments And Contingencies [Line Items]                    
Claim accrual recorded in selling, general and other administrative expenses                 1,000,000  
Reduction in selling,general and administrative expenses           $ 600,000        
Other Accrued Liabilities [Member]                    
Commitments And Contingencies [Line Items]                    
Claim accrual recorded in other accrued liabilities                 $ 1,000,000